INTRODUCTION: An artificial complete skin (dermis and epidermis) model has been developed in the Tissue engineering unit of the Centro Comunitario de Sangre y Tejidos del Principado de Asturias (CCST) and CIEMAT. This engineered skin has been employed for the treatment of severe epithelial injuries. In this paper, the clinical results obtained with this engineered skin during the last 18 months were evaluated. PATIENTS, MATERIAL AND METHODS: (a) Culture: Cells (fibroblasts and keratinocytes) were obtained from biopsies by a double enzymatic digestion. After an expansion period, fibroblasts were seeded in an artificial dermis based on human plasma. Keratinocytes were seeded over this dermal surface. (b) PATIENTS: 20 skin biopsies were processed (13 burned patients, 5 giant nevus, 1 GVHD, 1 neurofibromatosis), which came from different hospitals across the country. About 97,525 cm(2) of engineered skin were cultured. RESULTS: The engineered skin took in all patients. The take percentage depended on previous pathology (burned patients 10-90%; non-critical patients 70-90%). The epithelization obtained was permanent in all cases. During the follow-up period, epithelial loss, blistering injuries or skin retractions were not observed. The aesthetic and functional results were acceptable. CONCLUSIONS: This artificial skin has demonstrated to be useful for the definitive treatment of patients with severe skin injuries. This work shows that it is possible to produce this prototype in an hospitalarian laboratory and distribute it to different hospitals across the country.
INTRODUCTION: An artificial complete skin (dermis and epidermis) model has been developed in the Tissue engineering unit of the Centro Comunitario de Sangre y Tejidos del Principado de Asturias (CCST) and CIEMAT. This engineered skin has been employed for the treatment of severe epithelial injuries. In this paper, the clinical results obtained with this engineered skin during the last 18 months were evaluated. PATIENTS, MATERIAL AND METHODS: (a) Culture: Cells (fibroblasts and keratinocytes) were obtained from biopsies by a double enzymatic digestion. After an expansion period, fibroblasts were seeded in an artificial dermis based on human plasma. Keratinocytes were seeded over this dermal surface. (b) PATIENTS: 20 skin biopsies were processed (13 burned patients, 5 giant nevus, 1 GVHD, 1 neurofibromatosis), which came from different hospitals across the country. About 97,525 cm(2) of engineered skin were cultured. RESULTS: The engineered skin took in all patients. The take percentage depended on previous pathology (burned patients 10-90%; non-critical patients 70-90%). The epithelization obtained was permanent in all cases. During the follow-up period, epithelial loss, blistering injuries or skin retractions were not observed. The aesthetic and functional results were acceptable. CONCLUSIONS: This artificial skin has demonstrated to be useful for the definitive treatment of patients with severe skin injuries. This work shows that it is possible to produce this prototype in an hospitalarian laboratory and distribute it to different hospitals across the country.
Authors: Sara Guerrero-Aspizua; Marta García; Rodolfo Murillas; Luisa Retamosa; Nuria Illera; Blanca Duarte; Almudena Holguín; Susana Puig; Maria Isabel Hernández; Alvaro Meana; Jose Luis Jorcano; Fernando Larcher; Marta Carretero; Marcela Del Río Journal: Am J Pathol Date: 2010-10-22 Impact factor: 4.307
Authors: Antoni Gostyński; Sara Llames; Marta García; María J Escamez; Lucía Martinez-Santamaria; Miranda Nijenhuis; Alvaro Meana; Hendri H Pas; Fernando Larcher; Anna M G Pasmooij; Marcel F Jonkman; Marcela Del Rio Journal: J Invest Dermatol Date: 2013-07-24 Impact factor: 8.551
Authors: Maia M Alexaline; Marina Trouillas; Muriel Nivet; Emilie Bourreau; Thomas Leclerc; Patrick Duhamel; Michele T Martin; Christelle Doucet; Nicolas O Fortunel; Jean-Jacques Lataillade Journal: Stem Cells Transl Med Date: 2015-04-06 Impact factor: 6.940
Authors: Marta García; Sara Llames; Eva García; Alvaro Meana; Natividad Cuadrado; Mar Recasens; Susana Puig; Eduardo Nagore; Nuria Illera; José Luis Jorcano; Marcela Del Rio; Fernando Larcher Journal: Am J Pathol Date: 2010-06-17 Impact factor: 4.307
Authors: Carlos C Chang; Eugene D Boland; Stuart K Williams; James B Hoying Journal: J Biomed Mater Res B Appl Biomater Date: 2011-04-18 Impact factor: 3.368
Authors: Sara Llames; Eva García-Pérez; Álvaro Meana; Fernando Larcher; Marcela del Río Journal: Tissue Eng Part B Rev Date: 2015-03-24 Impact factor: 6.389
Authors: B Cabello-Arista; Y Melgarejo-Ramírez; A Retana-Flores; V Martínez-López; E Márquez-Gutiérrez; J Almanza-Pérez; H Lecona; M L Reyes-Frías; C Ibarra; M E Martínez-Pardo; C Velasquillo; R Sánchez-Sánchez Journal: Cell Tissue Bank Date: 2022-01-20 Impact factor: 1.522
Authors: Andrés Montero; Cristina Quílez; Leticia Valencia; Paula Girón; José Luis Jorcano; Diego Velasco Journal: Int J Mol Sci Date: 2021-06-23 Impact factor: 5.923